You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Mar 7, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
Joel R Walker1,2, Mary P Hall1,2, Chad A Zimprich1,2
1Promega Biosciences LLC , 277 Granada Drive, San Luis Obispo, California 93401, United States.
Researchers developed novel NanoLuc (Nluc) luciferase inhibitors. These potent, cell-permeable and impermeable compounds offer high specificity and low toxicity, enabling new bioluminescent assay applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: